Omega-3 DHA Capsule By DermetRx Pharmaceuticals Overview & Drug Interactions
Check For Interactions With Omega-3 DHA Capsule
Supplement: Omega-3 DHA Capsule by DermetRx Pharmaceuticals
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Docosahexaenoic Acid
Ingredient Group | DHA (Docosahexaenoic Acid) |
---|---|
Category | fatty acid |
Eicosapentaenoic Acid
Ingredient Group | EPA (Eicosapentaenoic Acid) |
---|---|
Category | fatty acid |
- Fish Oil
Drugs that interact with Omega-3 DHA Capsule by DermetRx Pharmaceuticals
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
There were no interactions found with Omega-3 DHA Capsule. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.
Label Information
Supplement Facts:
Daily Value (DV) Target Group(s): | Pregnant and Lactating |
---|---|
Minimum serving Sizes: |
1 Capsule(s)
|
Maximum serving Sizes: |
1 Capsule(s)
|
UPC/BARCODE | 348948406301 |
Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
---|---|---|---|
Docosahexaenoic Acid |
230 mg
|
DHA (Docosahexaenoic Acid) |
|
Eicosapentaenoic Acid |
30 mg
|
EPA (Eicosapentaenoic Acid) |
|
Other Ingredients: |
Vitamin E
Forms
Gelatin
Glycerin
purified Water
|
---|
Label Statments:
FDA Statement of Identity |
- Prenatal Multi-vitamin/Mineral Supplement
|
---|---|
Formulation |
- Gluten Free
|
General Statements |
- DHA/EPA Capsule
- 6 blister cards; each containing 5 tablets and 5 capsules
|
Formula |
- Pre-Tabs(TM) DHA Prenatal Multi-vitamin/Mineral Tablets with DHA and Choline
- Indications and Usage: Pre-Tabs(TM) DHA is indicated to provide vitamin/mineral and omega-3 fatty acid supplementation to women throughout pregnancy, during the postnatal for both lactating and nonlactating mothers. Pre-Tabs DHA is also beneficial in improving the nutritional status of women prior to conception.
|
Precautions |
- Contraindications:This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
- Warnings: Ingestion of more than 3 grams of omega-fatty acids per day has been shown to have potential antithrombotic effects, including increased bleeding time and INR.
- Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis.
- Do not take more than the recommended amount.
- If you are pregnant, nursing, or taking any medications consult your doctor before use.
- Discontinue use and consult your doctor if any adverse reactions occur.
- Not intended for use by persons under the age of 18.
|
Suggested/Recommended/Usage/Directions |
- Dosage and Administration: Pre-Tabs(TM) DHA - One tablet and one soft gel capsule daily or as directed by a physician.
|
Brand IP Statement(s) |
- Pre-Tabs(TM) is a trademark of DermetRx LLC.
|
Seals/Symbols |
- DermetRx(TM) PHARMACEUTICALS
|
Brand Information
See all products by this brand
Distributed by | |
---|---|
Name | DermetRx Pharmaceuticals |
City | Gilbert |
State | AZ |
ZipCode | 85233 |
Phone Number | (877) 774-4949 |
Other | |
Web Address | www.dermetrx.com |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.